The agency says the Johnson & Johnson coronavirus vaccine should have a warning for a potential risk for rare blood clots even though it believes the shot’s benefits outweigh risks. The agency did not recommend stopping use of the vaccine.
Tag: European Medicines Agency
AstraZeneca Vaccine and Blood Clots: What Is Known So Far
In rare cases, an immune reaction has led to antibodies that caused a serious clotting disorder. But public health experts maintain the vaccine’s benefits far outweigh the risks for most people.
Blood Clots Linked to AZ Vaccine Stem From Rare Antibody Reaction
New studies from Germany and Norway examined cases involving mostly younger people who developed serious and sometimes fatal blood disorders.
AstraZeneca Vaccine Faces New Setbacks in U.K. and European Union
Britain said it would give alternative shots to people under 30, while the European regulator said it had found a ‘possible link’ with rare blood clots.
AstraZeneca Vaccine Faces Setbacks in U.K. and European Union
Britain said it would give alternative shots to people under 30, while the European regulator said it had found a ‘possible link’ with rare blood clots.
Possible Side Effects of AstraZeneca Vaccine Come Into Sharper Focus
Regulators may soon issue their first formal warnings about rare blood clots, threatening to cloud the global rollout of a cheap and easy-to-store vaccine.
More Covid-19 Vaccine Production Sites Have Been Approved in the E.U.
A top European drug agency gave a green light to new plants in the Netherlands, Germany and Switzerland for AstraZeneca, Pfizer-BioNTech and Moderna vaccines.
Why Supply Isn’t the Only Thing Stymying Europe’s Coronavirus Vaccine Rollout
Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.
Supply Isn’t the Only Thing Stymying Europe’s Vaccine Rollout
Bureaucratic inertia, a diffusion of responsibility and logistical problems have seriously undercut vaccination efforts. In Italy, it’s the older population that bears the brunt.